+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 9Years +
All Genders
Healthy Volunteers
ID07017803

Study of Molecular Epidemiology and Genetic Types of Multidrug-Resistant Tuberculosis in Central Africa

Led by Centre de Recherche Médicale de Lambaréné · Updated on 2026-10-29

460

Participants Needed

8

Research Sites

3 weeks

Total Duration

AI-Summary

What This Trial Is About

Multidrug-resistant tuberculosis MDR-TB is a major health challenge in Central Africa. Researchers are studying the molecular epidemiology and genetic characteristics of MDR-TB strains to better understand how the disease spreads and evolves. This study focuses on mutations linked to resistance against important drugs like bedaquiline and quinolones, which could affect new treatment regimens involving Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin. The research also examines the role of TB lineage in infection outcomes and transmission patterns. This observational study involves screening GeneXpert positive TB patients aged 9 and older who can provide sputum samples. Participants already enrolled in a related tuberculosis epidemiology study may also be included without additional consent. The study collects and shares data on the genetic makeup of TB strains, focusing on identifying resistance mutations and transmission links within and between countries. Participants provide sputum samples for laboratory analysis to characterize drug resistance mutations and detect transmission chains. The primary outcomes measured over six months include the proportion of drug-resistant strains with known resistance mutations, the proportion with new mutations among unexplained resistance cases, and the proportion of cases showing transmission connections. The study aims to improve understanding of MDR-TB spread and resistance in the region, with participation lasting up to the study completion date in December 2026.

CONDITIONS

Brief Title

Molecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region

Research Team

J

Jabar Babatunde Pacome AGBO ACHIMI ABDUL

R

Rick elsy mirna NNOH DANSOU AKOUA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here